23andme dna - Search News

Order byBest matchMost fresh

23andMe, DNA and Regeneron

Digest more

Can I Delete My 23andMe DNA? Everything to Know as Firm Sells to Regeneron

CNET on MSN · 18h

· 17h · on MSN

23andMe To Be Sold in Bankruptcy: What It Means for Your DNA Data

· 3h · on MSN

Pharmaceutical company Regeneron buying 23andMe for $256 million

Regeneron agrees to buy bankrupt 23andMe

Regeneron Pharmaceuticals said on Monday it will buy genetic testing firm 23andMe Holding for $256 million through a bankruptcy auction, and promised to prioritize the ethical use of customers' DNA da...

· 21h

· 1d

Struggling DNA testing firm 23andMe to be bought for $256m

· 22h

23andMe (and Your Genetic Data) Sold to Regeneron in Bankruptcy Auction

Genetic data will be safeguarded with 23andMe sale, drugmaker vows

Regeneron Pharmaceuticals said Monday it will acquire 23andMe’s DNA testing business and most of its assets out of bankruptcy and pledged to continue offering the popular consumer service and adopt it...

· 18h

· 1d

23andMe sells its most valuable asset to biotech company Regeneron, which promises to keep your DNA private

· 1d

Biotechnology company Regeneron buying 23andMe for $256 million

Timeline: 23andMe’s Journey From DNA Testing Pioneer to Bankruptcy Sale

What happened to 23andMe? Here's a look at its history from launch to bankruptcy and acquisition by Regeneron.

23andMe was once worth $6 billion. What's left of the DNA testing startup is being bought for $256 million.

Regeneron is buying the assets of 23andMe, which filed for Chapter 11 bankruptcy in March after facing a series of hurdles including a data breach.

A drug developer is buying 23andMe - what does that mean for your DNA data?

The top bidder in the DNA testing firm's bankruptcy auction, Regeneron vows to prioritize the privacy, security, and ethical use of customer data.

Daily Voice Somerset County, NJ on MSN3h

Westchester-Based Regeneron Buying Bankrupt 23andMe For $256M, Pledges To Protect DNA Data

Regeneron Pharmaceuticals will acquire embattled DNA testing company 23andMe in a $256 million court-supervised sale, promising to honor existing privacy protections and continue consumer services with no changes.